Preradiation Chemotherapy for Adult High-risk Medulloblastoma A Trial of the ECOG-ACRIN Cancer Research Group (E4397) Article

Moots, Paul L, O'Neill, Anne, Londer, Harold et al. (2018). Preradiation Chemotherapy for Adult High-risk Medulloblastoma A Trial of the ECOG-ACRIN Cancer Research Group (E4397) . AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 41(6), 588-594. 10.1097/COC.0000000000000326

Open Access

cited authors

  • Moots, Paul L; O'Neill, Anne; Londer, Harold; Mehta, Minesh; Blumenthal, Deborah T; Barger, Geoffrey R; Grunnet, Margaret L; Grossman, Stuart; Gilbert, Mark R; Schiff, David

sustainable development goals

authors

publication date

  • June 1, 2018

webpage

published in

keywords

  • ADJUVANT CHEMOTHERAPY
  • BRAIN-TUMORS
  • CHILDREN
  • Life Sciences & Biomedicine
  • MULTIAGENT CHEMOTHERAPY
  • Oncology
  • PEDIATRIC MEDULLOBLASTOMA
  • PHASE-III
  • PROGNOSTIC-FACTORS
  • PROSPECTIVE RANDOMIZED-TRIAL
  • RADIATION-THERAPY
  • SURVIVAL
  • Science & Technology
  • adult medulloblastoma
  • phase II trial
  • preradiation chemotherapy

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 588

end page

  • 594

volume

  • 41

issue

  • 6